Microneedle, microneedle patch, monitoring system for environment inside body, and sensor device

The integration of optical waveguides and probes into microneedles within a microneedle patch and sensor device allows for non-invasive, efficient monitoring of internal body substances, addressing the complexity and invasiveness of existing methods by detecting light changes from reactions with target substances.

WO2024242199A1PCT designated stage expired Publication Date: 2024-11-28THE UNIV OF TOKYO +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/019267
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-25
Filing Date
2024-05-24
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current methods for monitoring the internal environment of the body are invasive and complex, lacking a minimally invasive and simple solution for measuring internal substances like blood and interstitial fluid without drawing blood.

Method used

A microneedle with an optical waveguide and optical probe is used, integrated into a microneedle patch and sensor device, allowing for non-invasive measurement of internal substances by detecting changes in light generated by reactions with target substances within the body.

Benefits of technology

Enables minimally invasive and simple measurement of internal body environments by using microneedles to detect changes in light generated by optical probes reacting with target substances, providing accurate and efficient monitoring of substances like oxygen and biomarkers.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024019267_28112024_PF_FP_ABST
    Figure JP2024019267_28112024_PF_FP_ABST
Patent Text Reader

Abstract

This microneedle includes: a needle part having an optical waveguide; and a needle substrate part having a first surface on which the needle part is formed and a second surface on which the needle part is not formed. The second surface has a region which has a deviation from flatness of 300nm or less. Said region includes a region which corresponds to the region of the first surface where the needle part is formed.
Need to check novelty before this filing date? Find Prior Art

Description

Microneedles, microneedle patches, internal body environment monitoring systems, and sensor devices

[0001] The present invention relates to a microneedle, a microneedle patch, an internal body environment monitoring system, and a sensor device. This application claims priority to Japanese Patent Application No. 2023-086510, filed on May 25, 2023, the contents of which are incorporated herein by reference.

[0002] Microneedles are used as medical devices for transdermal administration of drugs. Because they are minimally invasive to the body, they can be used outside of medical institutions, such as at home. Non-Patent Document 1 describes a technique for fabricating high-aspect-ratio microneedles that can reach subcutaneous tissue.

[0003] Y. Kanda et al., Mechanical strength evaluation of crystalline poly(L-lactic acid) fabricated by replica micromolding for bioabsorbable microneedle devices. Japanese Journal of Applied Physics 58, SDDK05 (2019).

[0004] By applying microneedles to a sensor device, it is possible to easily measure the internal environment of the body, such as by analyzing blood and / or interstitial fluid, without taking blood samples.

[0005] Therefore, an object of the present invention is to provide a microneedle suitable for measuring the internal body environment in a minimally invasive and simple manner, a microneedle patch using the microneedle, an internal body environment monitoring system, and a sensor device.

[0006] The present invention includes the following aspects. [1] A microneedle including a needle portion having an optical waveguide, and a needle substrate portion having a first surface on which the needle portion is formed and a second surface on which the needle portion is not formed, wherein the second surface has a region with a flatness of 300 nm or less, the region including a region on the first surface on which the needle portion is formed. [2] The microneedle described in [1], wherein the second surface has a light-focusing portion that focuses light incident from the second surface onto the needle portion. [3] The microneedle described in [1] or [2], wherein the needle substrate portion includes an alignment mark. [4] The microneedle described in any one of [1] to [3], wherein the needle portion includes an optical probe, and the optical probe includes a substance that changes the state of light generated by excitation light upon reaction with a target substance in a living body. [5] The microneedle according to [4], wherein the needle portion has at least one recess on its side, and the recess is filled with a support material that carries the optical probe. [6] The microneedle according to any one of [1] to [5], wherein the tip diameter of the needle portion is 50 to 300 μm. [7] The microneedle according to any one of [1] to [6], wherein the length of the needle portion is 0.05 to 5 mm. [8] The microneedle according to [7], wherein the length of the needle portion is 2 to 5 mm. [9] A microneedle patch comprising the microneedle according to any one of [1] to [8] and a fixing member that fixes the microneedle to the skin of a subject.

[10] A system for monitoring an internal environment comprising the microneedle patch according to [9] and a measuring device equipped with a light source and a photodetector.

[11] A sensor device comprising the microneedle according to any one of [1] to [8], a light source, and a photodetector.

[0007] According to the present invention, there are provided a microneedle suitable for measuring the internal body environment in a minimally invasive and simple manner, a microneedle patch using the microneedle, an internal body environment monitoring system, and a sensor device.

[0008] It is a schematic diagram showing a micro-needle patch of an embodiment. It is a schematic diagram showing a micro-needle patch of an embodiment. It is a schematic diagram showing a micro-needle of an embodiment. It is a photograph showing an example of a micro-needle. It is a photograph showing an example of a recess formed in the needle portion. It is a schematic diagram showing a micro-needle patch of an embodiment. It is a schematic diagram showing a micro-needle patch of an embodiment. It is a schematic diagram showing a body environment monitoring system of an embodiment. It is a diagram showing the configuration of a measuring device of an embodiment. It is a flowchart showing an operation example of a measuring device of an embodiment. It is a schematic diagram showing an example of a reaction between an optical probe (P) and a target substance (T). It is a perspective view schematically showing the appearance of a sensor device of an embodiment. It is a rear view schematically showing a sensor device of an embodiment. It is a cross-sectional view taken along the B-B cutting line of the sensor device of FIG. 13A. It is a schematic diagram showing an enlarged view of the needle portion of a sensor device of an embodiment. It is a diagram showing the configuration of a sensor device of an embodiment. It is a flowchart showing an operation example of a sensor device of an embodiment. It is a schematic diagram showing the state of the needle portion when a sensor device of an embodiment is inserted into the skin. It is a schematic diagram showing an example of a reaction between an optical probe (P) and a target substance (T). It is a rear view schematically showing a sensor device of the second embodiment. It is a cross-sectional view taken along the B-B cutting line of the sensor device of FIG. 1MA. It is a schematic diagram showing an outline of a method for manufacturing a micro-needle used in an example. It is a schematic diagram showing an outline of a phosphorescence measurement system used in Example 1. It shows the measurement results of phosphorescence lifetime in Example 1. It shows the relationship between the phosphorescence lifetime measured in Example 1 and the oxygen partial pressure. It is a schematic diagram showing an outline of a microscopic fluorescence spectroscopy system equipped with a human skin tissue model used in Example 2. It shows the relationship between the fluorescence signal intensity measured in Example 2 and the fluorescent label DDS.

[0009] Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings as appropriate. In the drawings, the same or corresponding parts are denoted by the same or corresponding reference numerals, and redundant descriptions are omitted. The dimensional ratios in each figure are exaggerated for the purpose of explanation and do not necessarily match the actual dimensional ratios.

[0010] [Microneedle] The first aspect is a microneedle. The microneedle includes a needle portion and a needle substrate portion. The needle portion has an optical waveguide. The needle substrate portion has a first surface on which the needle portion is formed and a second surface on which the needle portion is not formed. The second surface has a region with a flatness of 300 nm or less. The region includes a region on the first surface corresponding to the region on which the needle portion is formed. A "microneedle" is a needle with a needle base diameter of less than 1 mm, and typically one or more needles are formed on a substrate.

[0011] FIG. 1 is a schematic diagram showing a microneedle according to one embodiment and a microneedle patch using the microneedle.

[0012] The microneedle 40 includes a needle substrate portion 45 and a needle portion 41. The needle substrate portion 45 includes a first surface and a second surface. The needle portion 41 is formed on the first surface of the needle substrate portion 45. The second surface of the needle substrate portion 45 is the surface opposite to the first surface. The needle portion 41 is not formed on the second surface of the needle substrate portion 45.

[0013] The number of needle portions 41 on the first surface of the microneedle 40 is not particularly limited. The number of needle portions 41 may be, for example, 1 to 10. 8 pieces, 10-10 7 pieces, 10 2 ~10 6 pieces, 10 3 ~10 6 The microneedle 40 may be a microneedle array in which a plurality of needle portions 41 are arranged in an array.

[0014] The needle portion 41 has an optical waveguide. In one embodiment, the microneedle 40 has an optical waveguide that transmits light from the needle substrate portion 45 to the tip of the needle portion 41. Therefore, light incident from the second surface side of the needle substrate portion 45 is incident on the base of the needle portion 41 via the needle substrate portion 45 and is transmitted to the tip of the needle portion 41. Furthermore, light (fluorescence, phosphorescence, Raman scattered light, etc.) generated at the tip of the needle portion 41 is transmitted to the base of the needle portion 41 and exits from the second surface side of the needle substrate portion 45 via the needle substrate portion 45.

[0015] The microneedle 40 is preferably made of a transparent material, and more preferably made of an amorphous polymer. By making the microneedle 40 of a transparent material, an optical waveguide can be formed from the needle substrate portion 45 to the tip of the needle portion 41. Since the microneedle 40 is inserted into a living body, it is preferably made of a biocompatible polymer, and more preferably made of a bioabsorbable polymer. When the microneedle 40 is made of a bioabsorbable polymer, the risk of safety issues occurring is reduced even if a portion of the microneedle 40 remains in the living body. Examples of bioabsorbable polymer materials include, but are not limited to, polylactic acid (e.g., poly-L-lactic acid), polyglycolic acid, lactic acid-glycolic acid copolymer, polycaprolactone, etc. The microneedle 40 is preferably made of an amorphous form of these biocompatible polymers or bioabsorbable polymers.

[0016] The needle portion 41 may have a conical shape, a polygonal pyramid shape, etc. Examples of the polygonal pyramid shape include a triangular pyramid shape, a quadrangular pyramid shape, a pentagonal pyramid shape, a hexagonal pyramid shape, and an octagonal pyramid shape.

[0017] The length L of the needle portion 41 is preferably a length that allows it to reach the dermis. The length L of the needle portion 41 is, for example, 0.05 to 5 mm. The length L of the needle portion 41 may be 0.1 to 5 mm, 0.2 to 5 mm, 0.3 to 5 mm, 0.4 to 5 mm, or 0.5 to 5 mm. When the tip of the needle portion is to reach the subcutaneous tissue, the length L of the needle portion 41 is preferably 2 to 5 mm, and more preferably 2 to 3 mm.

[0018] The tip diameter D1 (maximum diameter of the tip) of the needle portion 41 is preferably 50 to 300 μm, more preferably 60 to 200 μm, and even more preferably 80 to 150 μm. When the tip diameter D1 of the needle portion 41 is within the above-mentioned preferred range, pain upon insertion can be reduced and deformation of the needle tip can be avoided. The shape of the tip of the needle portion 41 is not particularly limited, but examples include a hemisphere, a truncated cone, and a truncated polygonal pyramid (e.g., a truncated triangular pyramid, a truncated square pyramid, a truncated pentagonal pyramid, a truncated hexagonal pyramid, and a truncated octagonal pyramid). The base diameter D2 (maximum diameter of the base) of the needle portion 41 is preferably 200 to 800 μm, more preferably 300 to 700 μm, and even more preferably 400 to 600 μm. When the base diameter D2 of the needle portion 41 is within the above-mentioned preferred range, pain upon insertion can be reduced.

[0019] The thickness of the needle base plate portion 45 is not particularly limited, but can be set within the range of, for example, 100 to 5000 μm, 300 to 2000 μm, or 500 to 1000 μm.

[0020] The second surface of the needle substrate portion 45 has a region (hereinafter also referred to as a "flat region") having a flatness of 300 nm or less. If light irradiated onto the second surface is efficiently introduced into the needle portion 41 via the needle substrate portion 45, the flatness can be considered to be 300 nm or less. In this specification, flatness refers to the arithmetic mean roughness Ra. Flatness (arithmetic mean roughness) can be measured in accordance with JIS B 0601:2001. The flatness of the flat region is preferably 200 nm or less, more preferably 100 nm or less, and even more preferably 50 nm or less. The flatness of the flat region may be, for example, 0.01 to 300 nm, 0.1 to 300 nm, 1 to 300 nm, 0.1 to 200 nm, 1 to 200 nm, 0.1 to 100 nm, 1 to 100 nm, 0.1 to 50 nm, or 1 to 50 nm.

[0021] The flat region on the second surface includes a region corresponding to the region on the first surface where the needle portion 41 is formed. That is, the region on the backside of the region where the needle portion 41 is formed is a flat region. Because the region on the second surface corresponding to the needle portion 41 is a flat region, reflection of light irradiated onto the second surface is suppressed. Therefore, light irradiated onto the second surface is efficiently introduced into the needle portion 41 via the needle substrate portion 45. The second surface may be entirely flat, or may be partially flat. When a portion of the second surface is a flat region, the flat region includes at least a region corresponding to the region on the first surface where the needle portion 41 is formed.

[0022] The second surface may have a light collecting portion that collects light incident from the second surface onto the needle portion. In FIG. 1 , the microneedle 40 has a light collecting portion 47. The light collecting portion 47 is provided at a position corresponding to the needle portion 41. The light collecting portion 47 is formed as a convex portion in the shape of a single-sided convex lens. By having the light collecting portion 47 on the second surface, light incident from the second surface is collected onto the needle portion 41, and light can be efficiently introduced into the needle portion 41.

[0023] The microneedle may have an alignment mark. In FIG. 1 , the microneedle 40 has an alignment mark 46. The alignment mark is used by a light irradiation device that irradiates the microneedle 40 with excitation light, a light measurement device that measures the light emitted from the microneedle 40, or a light irradiation measurement device that irradiates the microneedle 40 with excitation light and measures the light emitted from the microneedle 40 to detect the position of the microneedle 40 and perform alignment. The number and position of the alignment marks 46 are not particularly limited. Examples of the number of alignment marks 46 include 1 to 20, 1 to 10, 1 to 8, 1 to 6, 1 to 5, 1 to 4, 1 to 3, 2 to 20, 2 to 10, 2 to 8, 2 to 6, 2 to 5, 2 to 4, 2 to 3, or 1 to 2. From the viewpoint of performing alignment more accurately, two or more alignment marks 46 are preferred. The position where the alignment mark 46 is present is preferably outside the area corresponding to the needle portion 41. By providing the alignment mark 46 outside the area corresponding to the needle portion 41, it is possible to prevent the alignment mark 46 from interfering with the introduction and emission of light into and from the needle portion 41.

[0024] The needle portion preferably includes an optical probe. "Optical probe" refers to a probe that detects a target substance in a living body by optical action. The optical probe includes a substance that generates light (fluorescence, phosphorescence, Raman scattering, etc.) in response to excitation light. The state of the light generated by the substance changes upon reaction with the target substance in the living body.

[0025] The microneedle 40 has at least one recess 42 on the side surface of the needle portion 41. The recess 42 is filled with a support material 43 containing an optical probe P. The optical probe P contains a substance that reacts with a target substance T in a living body. The optical probe P contains a substance that changes light (fluorescence, phosphorescence, Raman scattered light, or the like) generated in response to excitation light emitted by the light source 30 upon reaction with the target substance T.

[0026] The recess 42 is preferably disposed on the side surface near the tip of the needle portion 41. By having the recess 42 near the tip of the needle portion 41, the recess 42 can reach the dermis or subcutaneous tissue when the needle portion 41 is inserted into a living body. The distance d2 from the recess 42 to the base of the needle portion 41 is, for example, 0.04 to 4.5 mm. When the needle portion 41 is to reach the subcutaneous tissue, the distance d2 is, for example, 2 to 4.5 mm. The distance d1 from the tip of the needle portion 41 to the recess 42 is, for example, 10 to 500 μm, or 20 to 300 μm. If the distance (length L) from the base to the tip of the needle portion 41 is divided into 100, with the base of the needle portion 41 being 0 and the tip of the needle portion 41 being 100, the recess 42 is preferably positioned in the range of 50 to 99, more preferably in the range of 60 to 95, and even more preferably in the range of 70 to 95.

[0027] The size of the recess 42 is not particularly limited. From the viewpoint of the strength of the needle portion 41, the volume of the recess 42 is preferably 40% (v / v) or less, more preferably 30% (v / v) or less, even more preferably 20% (v / v) or less, and even more preferably 10% (v / v) or less, of the volume (100% (v / v)) when the region of the needle portion 41 where the recess 42 is present is sliced. The capacity of the recess 42 may be any size that allows the optical probe P to be present to an extent that it can measure the target substance T in a living body. Examples of the capacity of the recess 42 include 0.1 pL to 500 nL, 1 pL to 500 nL, and 10 pL to 500 nL.

[0028] The support material 43 filled in the recess 42 is preferably biocompatible. The support material 43 has a structure capable of supporting the optical probe P. The support material 43 preferably has a crosslinked structure of polymer chains or a porous structure, and is capable of allowing water to penetrate into the interior. Examples of the support material 43 include, but are not limited to, hydrogels such as polyethylene glycol, hyaluronic acid, gelatin, collagen, and alginic acid; perfluorocarbon materials such as Nafion; inorganic porous materials such as porous silica, porous ceramics, and porous glass; and organic porous materials such as metal-organic frameworks.

[0029] The optical probe P contains a substance that reacts with a target substance T in a living body. "Reacting with a target substance" may mean binding to the target substance or being converted into another substance by the target substance. The optical probe P may contain a substance that binds to the target substance T or may contain a substance that is converted into another substance by reacting with the target substance. The optical probe P changes the state of light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by excitation light from a light source through the reaction. "The state of light changes" refers to a change in one or more characteristics selected from the group consisting of light intensity (fluorescence intensity, phosphorescence intensity, Raman scattered light intensity, etc.), light wavelength (fluorescence wavelength, phosphorescence wavelength, Raman scattered light wavelength, etc.), and light decay time (fluorescence decay time, phosphorescence decay time, Raman scattered light decay time, etc.) before and after the reaction. For example, the optical probe P may not emit light before the reaction but emit light after the reaction; it may emit light before the reaction and then disappear after the reaction; it may have a decreased light intensity after the reaction compared to before the reaction; or it may have an increased light intensity after the reaction compared to before the reaction. Alternatively, the wavelength of light generated by excitation light may change before and after the reaction, or the decay time of light generated by excitation light may be longer after the reaction than before the reaction, or the decay time of light generated by excitation light may be shorter after the reaction than before the reaction.

[0030] The optical probe P can be appropriately selected depending on the target substance T. Examples of the target substance T include oxygen, biomarkers for various diseases (peptides, proteins, fatty acids, miRNA, low molecular weight compounds, etc.), etc. The target substance T is preferably a substance present in blood. Specific examples of biomarkers include heart failure markers (BNP, NT-proBNP, etc.), tumor markers (PSA, CEA, CA19-9, CA125, etc.), etc. Examples of optical probes P include phosphorescent probes such as ruthenium complexes and platinum complexes (for measuring oxygen partial pressure); fluorescent probes using antibodies such as Q-body (Patent No. 5043237) (for measuring peptides or proteins); fluorescent probes using aptamers (for measuring low molecular weight compounds, peptides, or proteins); fluorescent probes using organic low molecular weight compounds (for measuring low molecular weight compounds, peptides, or proteins); and Raman scattering light probes using metal nanoparticles bound to antibodies, aptamers, or organic low molecular weight compounds (for measuring low molecular weight compounds, peptides, or proteins). The optical probe P is preferably chemically bonded to the support material 43. By chemically bonding the optical probe P to the support material 43, diffusion of the optical probe P into the living body when inserted into the skin can be suppressed. The chemical bonding method is not particularly limited and can be selected appropriately depending on the type of optical probe P. For example, a method of introducing functional groups that bond to the support material 43 and the optical probe P can be used. Combinations of functional groups include, but are not limited to, amino and hydroxy groups; amino and carboxy groups; amino and isocyanate groups; amino and NHS groups; and the like.

[0031] 2 is a schematic diagram showing a microneedle patch 200' including a microneedle 40' having a plurality of needle portions 41a, 41b. In the microneedle 40', a light collecting portion 47a and a light collecting portion 47b are formed on the second surface of the needle substrate portion 45 in regions corresponding to the needle portion 41a and the needle portion 41b, respectively. The light collected by the light collecting portion 47a is efficiently introduced into the needle portion 41a. The light collected by the light collecting portion 47b is efficiently introduced into the needle portion 41b.

[0032] In the microneedle 40', the needle portions 41a and 41b each have at least one recess 42a and 42b on their side surfaces. The recesses 42a and 42b are each filled with a support material containing an optical probe. The optical probes contained in the recesses 42a and 42b may be the same or different. For example, the optical probe contained in the recess 42a may react with a first target substance, and the optical probe contained in the recess 42a may react with a second target substance. In this case, two types of target substances can be measured using the microneedle 40'. The number of needle portions may be three or more. In this case, a light-collecting portion may be provided corresponding to each needle portion. Each needle portion may include an optical probe that reacts with a different target substance. In this case, a number of types of target substances corresponding to the number of types of optical probes can be measured.

[0033] The needle may be coated with a light-reflecting material such as metal. By coating the needle with a light-reflecting material, loss of light (excitation light, fluorescence, phosphorescence, Raman scattered light, etc.) propagating through the needle can be reduced, thereby improving the detection sensitivity of the target substance.

[0034] 3 is a schematic diagram showing a needle portion 41 provided with a light-reflecting layer 48. A specific example of the light-reflecting layer 48 is a metal layer. The light-reflecting layer 48 may cover the entire needle portion 41 except for the recessed portion 42, or may cover only a portion of the needle portion 41. When the needle portion 41 has the light-reflecting layer 48, it is preferable that the recessed portion 42 is not covered by the light-reflecting layer 48. Since the recessed portion 42 is not covered, the target substance can infiltrate into the recessed portion 42.

[0035] An example of a microneedle 40 is shown in Figure 4. An example of a recess 42 is shown in Figure 5. The microneedle 40 can be produced, for example, by the method shown in the Examples. The recess 42 can be formed at a desired position on the needle portion 41 by providing a protrusion on a mold used to produce the microneedle 40. The recess 42 can be filled with the support material 43 by immersing the needle portion 41 in the support material 43 containing the optical probe P.

[0036] The microneedle of this embodiment has a flat second surface of the needle substrate portion, so that excitation light irradiated onto the second surface of the needle substrate portion is efficiently introduced into the needle portion. The light introduced into the needle portion propagates through the optical waveguide of the needle portion to the tip of the needle portion. When the needle portion includes an optical probe, light generated by the optical probe in response to the excitation light propagates through the optical waveguide of the needle portion and exits from the second surface of the needle substrate portion. Alternatively, the excitation light propagates into a living body through the needle portion, and light generated by a target substance in the living body in response to the excitation light propagates through the optical waveguide of the needle portion and exits from the second surface of the needle substrate portion. By measuring the light emitted from these second surfaces, the target substance in the living body can be measured. The microneedle of this embodiment can be used in the microneedle patch, internal body environment monitoring system, and sensor device described below.

[0037] [Microneedle Patch] A second aspect is a microneedle patch. The microneedle patch includes the microneedle according to the first aspect and a fixing member that fixes the microneedle to the skin of a subject.

[0038] <Microneedle> The microneedle is the microneedle of the first embodiment. The description of the microneedle is the same as above.

[0039] <Fixing member> The fixing member is not particularly limited as long as it can fix the microneedles to the skin of the subject. The fixing member may include, for example, a base and an adhesive layer.

[0040] (Substrate) As the substrate, any material used for a skin patch can be used without any particular limitation. From the viewpoint of durability when applied to the skin, the substrate is preferably a water-resistant material. Examples of the substrate include resin films. Examples of resin films include polyesters such as polyethylene terephthalate (PET), polybutylene terephthalate (PBT), and polyethylene naphthalate (PEN); polyolefins such as polyethylene (PE) and polypropylene (PP); polyarylate, polyurethane, polycarbonate, polyamide, polyimide, ethylene-vinyl acetate copolymer, polyvinyl chloride, polytetrafluoroethylene, silicone, polysulfone, polylactic acid, and acrylic resins, but are not limited to these. From the viewpoint of high conformability to the skin and flexibility, resin films made of resins such as polyester, polyolefin, polyarylate, polycarbonate, polyamide, polyimide, and polysulfone are preferred as the substrate.

[0041] The thickness of the substrate is not particularly limited, but may be, for example, 3 to 200 μm, or may be 10 to 150 μm, or may be 30 to 100 μm. When the thickness of the substrate is 3 μm or more, the strength of the substrate is easily maintained. When the thickness of the substrate is 200 μm or less, the conformability to the skin is easily improved.

[0042] (Adhesive Layer) The adhesive used in the adhesive layer is not particularly limited and any adhesive used for skin patches can be used. Examples of the adhesive include acrylic adhesives, rubber adhesives, and silicone adhesives.

[0043] Examples of acrylic pressure-sensitive adhesives include pressure-sensitive adhesives containing acrylic polymers obtained by polymerizing a monomer mainly composed of an acrylic acid alkyl ester. The acrylic polymer may be a copolymer of an acrylic acid alkyl ester and another monomer. Examples of other monomers include acrylic acid esters other than acrylic acid alkyl esters (e.g., acrylic acid esters having a hydroxyl group, acrylic acid esters having a carboxyl group, acrylic acid esters having an ether group), and monomers other than acrylic acid esters (e.g., vinyl acetate, styrene).

[0044] Examples of rubber-based pressure-sensitive adhesives include pressure-sensitive adhesives obtained by adding 20 to 200 parts by mass of a tackifier (rosin-based resin, polyterpene resin, coumarone-indene resin, petroleum-based resin, terpene-phenol resin, etc.) to 100 parts by mass of a rubber elastic material (natural rubber, styrene-isoprene-styrene block copolymer, styrene-butadiene-styrene block copolymer, styrene-olefin-styrene block copolymer, polyisoprene, polybutene, polyisobutylene, ethylene-vinyl acetate copolymer, etc.).

[0045] Examples of silicone-based adhesives include adhesives containing polydimethylsiloxane as a main component.

[0046] 1 is a schematic diagram showing one embodiment of a microneedle patch. The microneedle patch 200 includes a microneedle 40 and a fixing member 210. The microneedle 40 has been described above. The microneedle 40 may have a plurality of needle portions, and the plurality of needle portions may be arranged in an array.

[0047] The fixing member 210 has a base 211 and an adhesive layer 212. The fixing member 210 is attached to the periphery of the microneedle 40 by the adhesive layer 212. When using the microneedle patch 200, the adhesive layer 212 attaches the microneedle patch 200 to the skin of a subject. Before using the microneedle patch 200, the adhesive layer 212 may be protected by a protective sheet. In this case, when using the microneedle patch 200, the protective sheet can be peeled off from the adhesive layer 212. The microneedle patch 200 may include a protective sheet 230 that protects the second surface of the needle substrate portion 45 of the microneedle 40. If the microneedle patch 200 is attached to the skin for a long period of time, the second surface of the needle substrate portion 45 may become dirty or damaged. During times when target substance measurement is not being performed, the second surface of the needle substrate part 45 can be protected by the protective sheet 230, thereby preventing the second surface from being soiled or damaged. When target substance measurement is required, the protective sheet 230 can be peeled off and measurement can be performed.

[0048] 2 is a schematic diagram showing an example of a microneedle patch. The microneedle patch 200′ is similar to the microneedle patch 200 shown in FIG. 1 except that a microneedle 40′ having multiple needle portions 41 a, 41 b is used.

[0049] FIG. 6 is a schematic diagram showing another embodiment of a microneedle patch. The microneedle 40 has been described above. The microneedle 40 may have a plurality of needle portions, and the plurality of needle portions may be arranged in an array. The microneedle patch 201 uses a fixing member 210' as a fixing member. The fixing member 210' includes a transparent substrate 211' and an adhesive layer 212'. The fixing member 210' is attached to the second surface of the needle substrate portion 45 by the adhesive layer 212' so as to cover the entire second surface. The fixing member 210' is formed from a light-transmitting material, and light can enter and exit the microneedles 40 via the fixing member 210'.

[0050] The transparent substrate 211' is formed from a light-transmitting material. Examples of the material of the transparent substrate 211' include a transparent resin film. Examples of the transparent resin film include the resin films listed above in (Substrate). The adhesive layer 212' is formed from a light-transmitting adhesive. Examples of the light-transmitting adhesive include an acrylic adhesive.

[0051] Before use of the microneedle patch 201, the adhesive layer 212' may be protected by a protective sheet. In this case, when using the microneedle patch 201, the protective sheet can be peeled off from the adhesive layer 212'. The microneedle patch 201 may also include a protective sheet 230 that protects the second surface of the needle substrate portion 45 of the microneedle 40. The protective sheet 230 can be attached to the second surface during times when measurement of the target substance is not being performed, and when measurement of the target substance is to be performed, the protective sheet 230 can be peeled off.

[0052] Figure 7 is a schematic diagram showing another example of a microneedle patch. The microneedle patch 202 includes a plurality of microneedles 40a, 40b and a fixing member 210'. The microneedle patch 202 is similar to the microneedle patch 201 shown in Figure 6 except that it includes a plurality of microneedles 40a, 40b. The description of the microneedles 40a, 40b is the same as that of the microneedle 40 above. The microneedles 40a, 40b may have a plurality of needle portions, and the plurality of needle portions may be arranged in an array.

[0053] The second surfaces of the multiple microneedles 40a, 40b are adhered to the adhesive layer 212' of the fixing member 210'. The number of microneedles attached to the fixing member 210' may be one as shown in Figure 6, or two or more as shown in Figure 7. The number of microneedles included in the microneedle patch may be, for example, 1 to 20, 1 to 10, 1 to 8, 1 to 6, 1 to 5, 1 to 3, or 1 to 2.

[0054] The multiple microneedles 40a, 40b each have a recess 42a, 42b. The recess 42a, 42b are each filled with a support material containing an optical probe. The optical probes contained in the recess 42a and the recess 42b may be the same or different. For example, the optical probe contained in the recess 42a may react with a first target substance, and the optical probe contained in the recess 42a may react with a second target substance. In this case, two types of target substances can be measured using the microneedle patch 202. When the microneedle patch 202 includes three or more microneedles, the needle portion of each microneedle may include an optical probe that reacts with a different target substance. In this case, the number of target substances that can be measured corresponds to the number of types of optical probes.

[0055] In one embodiment, the microneedle patch is used by being attached to the skin of a subject using a fixing member. When the microneedle patch is attached to the skin of a subject, the needle portion of the microneedle is inserted into the skin of the subject. With the microneedle patch attached to the skin of the subject, the target substance in the body of the subject can be measured by irradiating the microneedle patch with excitation light. If the needle portion includes an optical probe, the target substance in the body of the subject can be measured by measuring light (fluorescence, phosphorescence, Raman scattering, etc.) generated by the optical probe in response to the excitation light. Alternatively, the target substance in the body of the subject can be measured by measuring light (fluorescence, phosphorescence, Raman scattering, etc.) generated by the target substance in the living body in response to the excitation light.

[0056] The microneedle patch may be replaced after one measurement, or multiple measurements may be performed using the same microneedle patch. The period for which one microneedle patch is used may be, for example, from one day to one month, one to 15 days, one to 10 days, one to 7 days, one to 4 days, or one to 2 days. The microneedle patch may remain attached to the subject's skin during this period.

[0057] The microneedle patch can be applied to humans and non-human animals. Non-human animals include mammals. Mammals include pets (dogs, cats, rabbits, etc.) and livestock (cows, pigs, goats, sheep, etc.). The microneedle patch of this embodiment can be used in the internal environment monitoring set described below.

[0058] [Internal Environment Monitoring System] A third aspect is an internal environment monitoring system. The internal environment monitoring system includes the microneedle patch according to the second aspect and a measuring device. The measuring device includes a light source and a photodetector.

[0059] 8 is a schematic diagram showing an embodiment of an internal environment monitoring system. The internal environment monitoring system 400 includes a microneedle patch 200 and a measurement device 300. The internal environment refers to the internal environment of the subject being monitored. Specifically, the internal environment may be the state of the subject's bodily fluids. More specifically, the internal environment may be the concentration of a target substance in the subject's bodily fluids. Examples of bodily fluids include blood, tissue fluid, and interstitial fluid.

[0060] <Microneedle Patch> The microneedle patch is the microneedle patch of the second embodiment. The description of the microneedle patch is the same as above.

[0061] <Measuring Device> The measuring device includes a light source and a photodetector. The light source irradiates excitation light onto the second surface of the microneedle. If the microneedle includes an optical probe, the excitation light excites the optical probe to generate light (fluorescence, phosphorescence, Raman scattered light, etc.). Alternatively, the excitation light excites a target substance in a living body to generate light (fluorescence, phosphorescence, Raman scattered light, etc.). The photodetector detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated from the optical probe by the excitation light. Alternatively, the photodetector detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated from the target substance in a living body by the excitation light. The measuring device may have a function of calculating the amount of the target substance in a living body from the state (intensity, wavelength, decay time, etc.) of the light detected by the photodetector.

[0062] Fig. 8 is a schematic diagram showing an embodiment of a biological environment monitoring system. The biological environment monitoring system 400 includes a microneedle patch 200 and a measurement device 300. Fig. 8 shows a state in which the needle portion 41 of the microneedle 40 has been inserted into the skin of a subject. In Fig. 8, the tip of the needle portion 41 of the microneedle 40 is long enough not to reach the subcutaneous tissue. The needle portion 41 may be made longer (for example, the length L is 2 to 5 mm) so that the tip of the needle portion 41 reaches the subcutaneous tissue.

[0063] The microneedle patch 200 is the same as the microneedle patch 200 shown in FIG.

[0064] The measuring device 300 has a housing 310 provided with a display unit 311, an input unit 312, and a light-transmitting unit 313. The housing 310 houses the photodetector 20, the light source 30, and various modules that realize the functions of the measuring device. The display unit 311 displays, for example, the measurement results of the measuring device. The display unit 311 is composed of, for example, a display. Examples of displays include a CRT (cathode ray tube) display, a liquid crystal display, and an organic EL (electroluminescence) display. The input unit 312 is a switch for turning the power of the measuring device 300 on and off. In addition to the function of turning the power on and off, the input unit 312 may also have the function of switching the display state of the display unit 311 and the function of switching the light emission state of the light source 30. The light-transmitting unit 313 is composed of a material that transmits light. Examples of light-transmitting materials include transparent glass and transparent polymers (amorphous polymers, etc.). Examples of transparent polymers include, but are not limited to, polycarbonate, acrylic resin, polyethylene terephthalate, polyvinyl chloride, amorphous polyester, cyclic olefin polymer, and polyethylene. The light-transmitting portion 313 may be composed of a transparent polymer plate or a transparent glass plate. The light-transmitting portion 313 transmits the excitation light generated by the light source 30 and the light emitted from the second surface of the needle substrate portion 45. The excitation light generated by the light source 30 passes through the light-transmitting portion 313 and is transmitted to the microneedle patch 200. The light emitted from the microneedle patch 200 passes through the light-transmitting portion 313 and is transmitted into the housing 310.

[0065] (Light Source) The light source 30 has a function of irradiating the microneedle patch 200 with excitation light. The excitation light excites the optical probe P filled in the recess 42 of the microneedle 40, causing it to generate light (fluorescence, phosphorescence, Raman scattered light, etc.). The light source 30 is not particularly limited as long as it is capable of irradiating excitation light. As the light source 30, for example, a laser light source (solid-state laser, semiconductor laser, etc.) or a light-emitting diode (LED), etc., can be used.

[0066] The light source 30 is arranged so that excitation light can be incident from the base of the needle portion 41 of the microneedle 40 in the direction of the tip. The number of light sources 30 may be one or more, and may be multiple. When the microneedle patch 200 has multiple needle portions 41, the multiple light sources 30 may be arranged to correspond to each needle portion 41. The multiple light sources 30 may be arranged in an array. When the multiple needle portions 41 include different types of optical probes for each needle portion 41 or for each group of needle portions 41, the multiple light sources 30 may each generate excitation light that excites each optical probe. In other words, multiple types of light sources 30 that generate excitation light for the multiple types of optical probes may be used depending on the types of optical probes.

[0067] (Photodetector) The photodetector 20 has the function of detecting light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe P. The photodetector 20 can convert the light intensity of light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe P into an electrical signal. For example, a photodiode or the like can be used as the photodetector 20. The photodetector 20 is disposed in the housing 310 so as to be able to receive light emitted from the second surface of the needle substrate portion 45 of the microneedle 40. In the example of FIG. 8 , the light emitted from the needle substrate portion 45 is reflected by the dichroic mirror 370 and received by the photodetector 20.

[0068] (Other Configurations) The measuring device 300 may include modules that realize various functions of the measuring device, such as the camera 360, the dichroic mirror 370, and the circuit board 50.

[0069] The camera 360 is used to acquire an image for alignment with the microneedle patch 200. The camera 360 acquires an image of the microneedle patch 200 including the alignment mark 46. As the camera 360, for example, a CCD camera, a CMOS camera, or the like can be used.

[0070] The dichroic mirror 370 has the function of transmitting excitation light generated by the light source 30 and reflecting light (fluorescence, phosphorescence, Raman scattered light, etc.) emitted from the second surface of the needle substrate portion 45. The dichroic mirror 370 is disposed between the light source 30 and the light transmitting portion 313. The excitation light generated from the light source 30 passes through the dichroic mirror 370 and the light transmitting portion 313 and enters the inside of the microneedle 40. The light emitted from the microneedle 40 passes through the light transmitting portion 313, is reflected by the dichroic mirror 370, and is received by the photodetector 20. The measuring device 300 may include optical components such as a bandpass filter, a mirror, a collimating lens, a spectroscope, etc. in addition to the dichroic mirror 370, or instead of the dichroic mirror 370.

[0071] The circuit board 50 has a function of controlling the operations of the light source 30, the photodetector 20, and various modules included in the measurement device 300. The circuit board 50 may have a function of calculating the concentration of a target substance in a living body from the light intensity detected by the photodetector 20. The circuit board 50 may have a function of controlling the output of the calculation result to the display unit 11. The circuit board 50 may have a function of processing an image acquired by the camera 360 and acquiring position information of the alignment mark 46. The circuit board 50 may have a function of outputting the position information of the alignment mark 46 to the display unit 311. The circuit board 50 may have a function of determining whether the measurement device 300 is in a position where measurement can be performed, based on the position information of the alignment mark 46.

[0072] The circuit board 50 may include a driver IC, a microcontroller, a communication unit, etc. The driver IC may have a function of controlling the operation of the light source 30 and the photodetector 20. The microcontroller may have a function of controlling the driver IC in response to an external input. The microcontroller may have a function of calculating the concentration of the target substance from an electrical signal generated in the photodetector 20. The microcontroller may have a function of outputting the concentration of the target substance to the display unit 11. The microcontroller may have a function of transmitting the concentration of the target substance to an external device via the communication unit. The communication unit communicates with the external device via a wired or wireless connection. The communication unit may be connected to the external device via a communication network. The communication network may refer to a general information communication network using electrical communication technology. For example, the communication network may include a LAN (Local Area Network), a WAN (Wide Area Network), the Internet, as well as a telephone communication line network, an optical fiber communication network, a cable communication network, a satellite communication network, etc.

[0073] In addition to the above configuration, the measuring device 300 may also include a power supply device such as a rechargeable battery.

[0074] The internal environment monitoring system 400 may include an external device that stores the measurement results obtained by the measuring device 300. The external device may be, for example, a computer connected to a LAN. The external device may also be a cloud server connected to a WAN or the Internet.

[0075] <Configuration Example> Fig. 9 shows a configuration example of the measurement device 300. The measurement device 300 includes a control unit 51, which controls the operation of each module. The control unit 51 is configured using a processor such as a CPU (Central Processing Unit) and a memory. The control unit 51 functions as a photodetector control unit 52, a light source control unit 53, an alignment control unit 58, a target substance concentration calculation unit 55, an input / output control unit 56, and a communication control unit 57 when the processor executes a program. All or part of the functions of the control unit 51 may be realized using hardware such as an ASIC (Application Specific Integrated Circuit), a PLD (Programmable Logic Device), or an FPGA (Field Programmable Gate Array). The program may be recorded on a computer-readable recording medium. Examples of the computer-readable recording medium include portable media such as a memory card and a semiconductor storage device (e.g., an SSD (Solid State Drive)), and storage devices such as a hard disk or semiconductor storage device built into a computer system. The program may be transmitted via a telecommunications line. Depending on the processing power of the processor, a GPU (Graphics Processing Unit) may be added to enhance image processing power. The control unit 51 may be mounted on the circuit board 50. The control unit 51 may be realized by the driver IC and microcontroller described above.

[0076] The photodetector control unit 52 controls the photodetector 20 and converts light received by the photodetector 20 (such as fluorescence, phosphorescence, or Raman scattered light) into an electrical signal. The light source control unit 53 controls the light source 30 and causes the light source 30 to generate excitation light or stop generating the excitation light. The alignment control unit 58 controls the camera 360 to capture images of the microneedle 40, acquires position information of the alignment mark 46 by image analysis of the acquired image, and determines whether measurement can be performed based on the position information of the alignment mark 46. The target substance concentration calculation unit 55 receives the electrical signal generated by the photodetector 20 and calculates the concentration of the target substance T in the living body. Data necessary to calculate the in vivo concentration of the target substance T from the electrical signal may be stored in the memory unit 63. The target substance concentration calculation unit 55 may calculate the concentration of the target substance T by referring to the data stored in the memory unit 63. The input / output control unit 56 has a function of controlling the input / output unit 61, controlling input from the input / output unit 61, and causing the input / output unit 61 to output data. The communication control unit 57 has a function of controlling the communication unit 62, causing the communication unit 62 to transmit and receive data via wire or wirelessly.

[0077] The input / output unit 61 includes the display unit 11 and the input unit 12. In addition to these, the input / output unit 61 may include an input device such as a touch panel or a keyboard; and an output device such as a speaker. The communication unit 62 is configured to include a communication interface for connecting to an external device. The communication unit 62 communicates with the external device via a wired or wireless connection. The communication unit may include, for example, a NIC (Network Interface Card) and an antenna for wireless communication.

[0078] <Operation Example> Fig. 10 is a flowchart showing an operation example of the measuring device 300. In step S301, the power of the measuring device 300 is turned on by the input unit 312. In step S302, the alignment control unit 58 controls the camera 360 and the like to align the measuring device 300 with respect to the microneedle patch 200. The alignment control unit 58 aligns the measuring device 300 with respect to the microneedle 40 based on an image of the microneedle 40 acquired by the camera 360. The alignment control unit 58 controls the camera 360 to acquire an image of the microneedle 40. The alignment control unit 58 acquires position information of the alignment mark 46 by analyzing the image of the microneedle 40. The alignment control unit 58 determines whether the measuring device 300 is in a position where measurement can be performed based on the position information of the alignment mark 46. The alignment control unit 58 outputs a signal based on the determination.

[0079] In step S303, the light source control unit 53 controls the light source 30 to generate excitation light from the light source 30. Based on the signal output by the alignment control unit 58, the light source control unit 53 causes the light source 30 to generate excitation light when the measurement device 300 is in a position where measurement can be performed.

[0080] 8 , the excitation light generated from the light source 30 passes through the light transmitting portion 313 and enters the microneedle 40 from the second surface side of the needle substrate portion 45. The excitation light that enters the microneedle 40 is transmitted to the tip of the needle portion 41 via the optical waveguide within the microneedle 40. The excitation light also reaches the recess 42 present in the vicinity of the microneedle 40.

[0081] In step S304, the photodetector control unit controls the photodetector 20 to detect light (fluorescence, phosphorescence, Raman scattered light, or the like) generated from the optical probe P by the excitation light.

[0082] 11 is a schematic diagram showing the state when an optical probe P reacts with a target substance T in a living body. The excitation light generated from the light source 30 is transmitted to the tip of the needle portion 41 via an optical waveguide in the microneedle 40. The excitation light also reaches a recess 42 present in the vicinity of the microneedle 40.

[0083] The recess 42 is filled with a support material 43 containing an optical probe P. The support material 43 has a structure that allows water to infiltrate into the interior. For example, if the support material 43 is a hydrogel, polymer chains are cross-linked to form a network structure, and liquids such as water infiltrate the gaps in the network structure. When substances present in bodily fluids such as blood, interstitial fluid, and tissue fluid come into contact with the support material 43, they infiltrate into the support material 43 along with the bodily fluid. Polymers such as proteins can also infiltrate into the support material 43. When the tip of the needle portion 41 enters a blood vessel and the support material 43 comes into contact with blood, blood components infiltrate into the support material 43. If a target substance T is present in the blood, the target substance T also infiltrates into the support material 43. The target substance T that has infiltrated into the support material 43 reacts with the optical probe P present in the support material 43. The amount of target substance T that reacts with the optical probe P is proportional to the concentration of the target substance T in the bodily fluid. 11 shows an example in which the optical probe P binds to the target substance T as a reaction between the optical probe P and the target substance T. When the optical probe P reacts with the target substance T, the state of the light (fluorescence, phosphorescence, Raman scattered light, or the like) generated from the optical probe P by the excitation light changes. FIG. 11 shows an example in which the optical probe P generates fluorescence by binding to the target substance T.

[0084] Light (fluorescence, phosphorescence, Raman scattered light, etc.) generated from the optical probe P is transmitted to the needle substrate unit 45 via an optical waveguide within the microneedle 40. The light (fluorescence, phosphorescence, Raman scattered light, etc.) transmitted to the needle substrate unit 45 is emitted from the second surface side of the needle substrate unit 45. The emitted light is incident into the housing 310 of the measuring device 300 via the light transmitting unit 313. The light incident into the housing 310 is reflected by the dichroic mirror 370 and received by the photodetector 20. The light intensity (fluorescence intensity, phosphorescence intensity, Raman scattered light intensity, etc.) received by the photodetector 20 correlates with the amount of optical probe P that has reacted with the target substance T. The photodetector 20 converts the received light into an electrical signal and outputs it. The photodetector 20 may detect light of a specific wavelength and convert the light intensity of the specific wavelength into an electrical signal and output it. In this case, the measurement device 300 may include a bandpass filter, a spectrometer, or the like that transmits the wavelength. The photodetector 20 may detect the light intensity over time and convert the light intensity over time into an electrical signal. In this case, the decay time of the light can be measured by the attenuation of the light intensity.

[0085] In step S305, the target substance concentration calculation unit 55 calculates the concentration of the target substance based on the electrical signal output from the photodetector 20. In step S306, the target substance concentration calculated by the target substance concentration calculation unit 55 is output to the input / output unit 61 such as the display unit 11. This ends the operation flow. The target substance concentration output in step S306 may be stored in the memory unit 63 together with the date and time of measurement. Alternatively, it may be stored in an external device together with the date and time of measurement.

[0086] In the internal environment monitoring system of this embodiment, the microneedle patch is independent of the measurement device. Therefore, the microneedle patch can be left attached to the subject's skin. By performing periodic measurements using the measurement device, it is possible to monitor the target substance.

[0087] [Sensor Device] A fourth aspect is a sensor device. The sensor device of this embodiment includes the microneedle according to the first aspect, a light source, and a photodetector. The microneedle preferably includes an optical probe that reacts with a target substance in a living body. The light source preferably generates excitation light that excites the optical probe to generate light (such as fluorescence, phosphorescence, or Raman scattered light). The photodetector preferably detects the light (such as fluorescence, phosphorescence, or Raman scattered light) generated from the optical probe. The microneedle includes a needle substrate and a needle, and has an optical waveguide that transmits light from the needle substrate to the tip of the needle. The excitation light generated by the light source is transmitted to the optical probe via the optical waveguide. The light generated by the optical probe (such as fluorescence, phosphorescence, or Raman scattered light) is transmitted to the photodetector via the optical waveguide. The optical probe changes the state of the light (such as fluorescence, phosphorescence, or Raman scattered light) generated by the excitation light upon reaction with the target substance.

[0088] The sensor device of the fourth aspect is a sensor device that utilizes microneedle technology and can be used to measure substances present in a living body. The sensor device of the fourth aspect can be used to monitor the internal environment of the body. The sensor device of the fourth aspect can be used as a medical device for performing in vivo monitoring of biomarkers or administered drugs.

[0089] (First embodiment) FIG. 12 is a perspective view schematically illustrating the appearance of a sensor device according to one embodiment. The sensor device 1 includes a housing 10, a display unit 11, and an input unit 12. The housing 10 houses various modules that realize the functions of the sensor device, including a photodetector 20 and a light source 30, which will be described later. The display unit 11 displays, for example, measurement results from the sensor device. The display unit 11 is configured with a display. Examples of displays include a cathode ray tube (CRT) display, a liquid crystal display, and an organic electroluminescence (EL) display. The input unit 12 is a switch for turning the power of the sensor device 1 on and off. In addition to the function of turning the power on and off, the input unit 12 may also have functions such as switching the display state of the display unit 11 and switching the light emission state of the light source 30.

[0090] Fig. 13A is a rear view of the sensor device 1. Fig. 13B is a cross-sectional view taken along the line BB in Fig. 13A. Fig. 14 is a schematic diagram showing an enlarged view of one needle portion 41 of the microneedle 40.

[0091] A microneedle 40 is provided on the back surface of the sensor device 1. The microneedle 40 includes a needle portion 41 and a needle substrate portion 45. The microneedle 40 is provided on the back surface of the sensor device 1 by the needle substrate portion 45. A circuit board 50 including a light source 30 and a photodetector 20 is provided inside the housing 10 of the sensor device 1. The light source 30 and the photodetector 20 are provided on the surface of the circuit board 50 that faces the inner bottom surface of the housing 10.

[0092] <Microneedle> The microneedle 40 is mounted on the back surface of the sensor device 1 via the second surface of the needle substrate portion 45. The microneedle 40 may be disposable after each measurement. In this case, the microneedle 40 is detachably attached to the sensor device 1. The housing 10 may be provided with a microneedle 40 attachment portion for attaching the microneedle 40. The microneedle 40 attachment portion is preferably made of a material (e.g., a transparent material) that transmits excitation light from the light source 30 and light generated by the microneedle 40 (fluorescence, phosphorescence, Raman scattered light, etc.). Examples of materials that constitute the transparent material include transparent glass and transparent polymers (amorphous polymers, etc.). Examples of transparent polymers include, but are not limited to, polycarbonate, acrylic resin, polyethylene terephthalate, polyvinyl chloride, amorphous polyester, cyclic olefin polymer, polyethylene, etc.

[0093] The microneedle 40 has an optical waveguide that transmits light from the needle substrate 45 to the tip of the needle 41. Therefore, excitation light generated from the light source 30 is incident on the base of the needle 41 via the needle substrate 45 and is transmitted to the tip of the needle 41. Furthermore, fluorescence, phosphorescence, or Raman scattered light generated at the tip of the needle 41 is transmitted to the base of the needle 41 and received by the photodetector 20 via the needle substrate 45.

[0094] The microneedle 40 is the microneedle of the first embodiment. The description of the microneedle 40 is the same as that described above.

[0095] <Light Source, Photodetector> The housing 10 of the sensor device 1 houses a circuit board 50 equipped with a light source 30 and a photodetector 20. The light source 30 is arranged so that excitation light can be incident from the base of the needle portion 41 of the microneedle 40 in the direction of the tip. The photodetector 20 is arranged so that fluorescence generated at the tip of the needle portion 41 of the microneedle 40 can be received via the base of the needle portion 41. In Figures 13A and 13B, the light source 30 and the photodetector 20 are illustrated adjacent to each other in an area overlapping with the microneedle 40 for convenience, but their actual arrangement may be different. For example, multiple light sources 30 may be arranged in an array so as to correspond to the positions of multiple needle portions 41. Multiple photodetectors 20 may be arranged in an array so as to correspond to the positions of multiple needle portions 41.

[0096] The light source 30 generates excitation light that excites the optical probe. For example, a light-emitting diode (LED) can be used as the light source 30. As shown in FIG. 14 , a light source 30 may be provided for each needle portion 41. In this case, a micro LED element can be used as the light source 30.

[0097] The photodetector 20 detects light (such as fluorescence, phosphorescence, or Raman scattered light) generated by the optical probe or light generated by a target substance in a living body in response to excitation light. The photodetector 20 can convert the light intensity of the light (such as fluorescence, phosphorescence, or Raman scattered light) generated by the optical probe or the target substance into an electrical signal. As shown in FIG. 14 , a photodetector 20 may be provided for each needle 41. In this case, for example, a microphotodiode element can be used as the photodetector 20.

[0098] The circuit board 50 has a function of controlling the operation of the light source 30 and the photodetector 20. The circuit board 50 may have a function of calculating the concentration of a target substance in a living body from the light intensity detected by the photodetector 20. The circuit board 50 may have a function of controlling the output of the calculation result to the display unit 11. The circuit board 50 may include a driver IC, a microcontroller, a communication unit, etc. The driver IC may have a function of controlling the operation of the light source 30 and the photodetector 20. The microcontroller may have a function of controlling the driver IC in response to an external input. The microcontroller may have a function of calculating the concentration of the target substance from an electrical signal generated in the photodetector 20. The microcontroller may have a function of outputting the concentration of the target substance to the display unit 11. The microcontroller may have a function of transmitting the concentration of the target substance to an external device via a communication unit. The communication unit communicates with the external device via a wired or wireless connection. The communication unit may be connected to the external device via a communication network. The communication network may refer to a general information communication network using electrical communication technology. For example, the communication network includes a LAN (Local Area Network), a WAN (Wide Area Network), the Internet, as well as a telephone communication network, an optical fiber communication network, a cable communication network, and a satellite communication network.

[0099] <Configuration Example> Fig. 15 shows a configuration example of the sensor device 1. The sensor device 1 includes a control unit 51, which controls the operation of each module. The control unit 51 is configured using a processor such as a CPU (Central Processing Unit) and a memory. The control unit 51 functions as a photodetector control unit 52, a light source control unit 53, a microneedle control unit 54, a target substance concentration calculation unit 55, an input / output control unit 56, and a communication control unit 57 when the processor executes a program. All or part of the functions of the control unit 51 may be realized using hardware such as an ASIC (Application Specific Integrated Circuit), a PLD (Programmable Logic Device), or an FPGA (Field Programmable Gate Array). The program may be recorded on a computer-readable recording medium. Examples of the computer-readable recording medium include portable media such as a memory card and a semiconductor storage device (e.g., an SSD (Solid State Drive)), and storage devices such as a hard disk or semiconductor storage device built into a computer system. The program may be transmitted via a telecommunications line. Depending on the processing power of the processor, a GPU (Graphics Processing Unit) may be added to enhance image processing power. The control unit 51 may be mounted on the circuit board 50. The control unit 51 may be realized by the driver IC and microcontroller described above.

[0100] The photodetector control unit 52 controls the photodetector 20 and has the function of causing the photodetector 20 to convert the received fluorescence, phosphorescence, or Raman scattered light into an electrical signal. The light source control unit 53 controls the light source 30 and has the function of causing the light source 30 to generate excitation light or stop the generation of excitation light. The microneedle control unit controls the microneedle 40 and has the function of controlling the insertion of the microneedle 40 and controlling the attachment and detachment of the microneedle. The target substance concentration calculation unit 55 has the function of receiving the electrical signal generated by the photodetector 20 and calculating the concentration of the target substance T in the living body. Data necessary for calculating the in vivo concentration of the target substance T from the electrical signal may be stored in the memory unit 63. The target substance concentration calculation unit 55 may calculate the concentration of the target substance T by referring to the data stored in the memory unit 63. The input / output control unit 56 controls the input / output unit 61 and has the function of controlling input from the input / output unit 61 and causing the input / output unit 61 to output data. The communication control unit 57 has a function of controlling the communication unit 62 and causing the communication unit 62 to transmit and receive data via wired or wireless communication.

[0101] The input / output unit 61 includes the display unit 11 and the input unit 12. In addition to these, the input / output unit 61 may include an input device such as a touch panel or a keyboard; and an output device such as a speaker. The communication unit 62 is configured to include a communication interface for connecting to an external device. The communication unit 62 communicates with the external device via a wired or wireless connection. The communication unit may include, for example, a NIC (Network Interface Card) and an antenna for wireless communication.

[0102] The storage unit 63 is configured using a storage device such as a semiconductor storage device. The storage unit 63 may store a program executed by the control unit 51. The storage unit 63 may store the concentration of the target substance T calculated by the target substance concentration calculation unit 55, the measurement date and time, and subject data input from the input / output unit 61.

[0103] In addition to the above configuration, the sensor device 1 may include a power supply such as a rechargeable battery; a microneedle cover; optical components such as a bandpass filter, a mirror, a dichroic mirror, and a collimating lens; a mounting band; a protective pad, etc. The power supply supplies power to the sensor device 1 in response to input from the input unit 12. The microneedle cover may be provided on the outside of the microneedle 40 to protect the microneedle 40 when the sensor device 1 is not in use. The optical components may be installed within the housing 10 for adjusting the wavelength of the excitation light generated from the light source 30, adjusting the direction of the excitation light, adjusting the wavelength of light (fluorescence, phosphorescence, Raman scattered light, etc.) emitted from the microneedle 40, and / or adjusting the direction of the light (fluorescence, phosphorescence, Raman scattered light, etc.). When the sensor device 1 includes optical components, the photodetector 20 and the light source 30 may be disposed at a distance from the microneedle 40. By adjusting the type and arrangement of these optical components, the excitation light generated by the light source 30 can be incident on the microneedle 40. Furthermore, light (such as fluorescence, phosphorescence, or Raman scattered light) emitted from the microneedles 40 can be received by the photodetector 20. A wearing band may be attached to the sensor device 1 in order to wear the sensor device 1 at a desired position on the subject's body. The wearing band is preferably made of a stretchable material (e.g., a rubber band). A protective pad may be attached to the back surface of the sensor device 1 to protect the skin when the sensor device 1 is placed against the skin. The protective pad may be attached to the back surface of the housing 10 excluding the area where the needle portion 41 is placed.

[0104] <Operation Example> Fig. 16 is a flowchart showing an operation example of the sensor device 1. In step S101, the power of the sensor device 1 is turned on by the input unit 12. In step S102, the back surface of the sensor device 1 is brought into contact with the skin of a subject, and the needle portions 41 of the microneedles 40 are inserted into the skin of the subject. The needle portions 41 may be inserted into the skin by pressing the back surface of the sensor device 1 against the skin. Alternatively, the needle portions 41 may be inserted into the skin by the microneedle control unit 54 controlling the operation of the microneedles 40 based on input from the input unit 12, etc. For example, the microneedle control unit 54 may lower the microneedles 40, thereby inserting the microneedles into the skin.

[0105] In step S103, the light source control unit 53 controls the light source 30 by operating the input / output unit 61 such as the input unit 12, causing the light source 30 to generate excitation light. In step S104, the photodetector control unit controls the photodetector 20, causing the photodetector 20 to detect light (fluorescence, phosphorescence, or Raman scattered light) generated from the optical probe P or the target substance in response to the excitation light.

[0106] FIG. 17 is a schematic diagram showing the transmission of light when the needle portion 41 is inserted into the skin and excitation light is generated from the light source 30. FIG. 18 is a schematic diagram showing the state when the optical probe P reacts with a target substance T in a living body. In FIG. 17, the tip of the needle portion 41 reaches the subcutaneous tissue and comes into contact with a blood vessel present in the subcutaneous tissue. The subcutaneous tissue contains blood vessels that are larger than those present in the dermis. Therefore, by allowing the tip of the needle portion 41 to reach the subcutaneous tissue, the tip of the needle portion 41 is more likely to come into contact with a blood vessel. If the length L of the needle portion 41 is short (e.g., 0.05 to 2 mm), the tip of the needle portion 41 does not reach the subcutaneous tissue.

[0107] The excitation light generated from the light source 30 is transmitted to the tip of the needle portion 41 via an optical waveguide within the microneedle 40. The excitation light also reaches a recess 42 present in the vicinity of the microneedle 40.

[0108] The recess 42 is filled with a support material 43 containing an optical probe P. The support material 43 has a structure that allows water to infiltrate into the interior. For example, if the support material 43 is a hydrogel, polymer chains are cross-linked to form a network structure, and liquids such as water infiltrate the gaps in the network structure. When substances present in bodily fluids such as blood come into contact with the support material 43, they infiltrate into the support material 43 along with the bodily fluid. Polymers such as proteins can also infiltrate into the support material 43. When the tip of the needle portion 41 enters a blood vessel and the support material 43 comes into contact with blood, blood components infiltrate into the support material 43. If a target substance T is present in the blood, the target substance T also infiltrates into the support material 43. The target substance T that has infiltrated into the support material 43 reacts with the optical probe P present in the support material 43. The amount of target substance T that reacts with the optical probe P is proportional to the concentration of the target substance T in the blood. 18 shows an example in which the optical probe P binds to the target substance T as a reaction between the optical probe P and the target substance T. When the optical probe P reacts with the target substance T, the state of the light (fluorescence, phosphorescence, Raman scattered light, or the like) generated from the optical probe P by the excitation light changes. FIG. 18 shows an example in which the optical probe P generates fluorescence by binding to the target substance T.

[0109] Light (fluorescence, phosphorescence, Raman scattered light, etc.) generated from the optical probe P is transmitted to the needle substrate portion 45 via an optical waveguide within the microneedle 40. The light (fluorescence, phosphorescence, Raman scattered light, etc.) transmitted to the needle substrate portion 45 is detected by the photodetector 20. The intensity of the light detected by the photodetector 20 (fluorescence intensity, phosphorescence intensity, Raman scattered light intensity, etc.) correlates with the amount of optical probe P that has reacted with the target substance T. The photodetector 20 converts the received light (fluorescence, phosphorescence, Raman scattered light, etc.) into an electrical signal and outputs it. The photodetector 20 may detect light of a specific wavelength and convert the light intensity of the specific wavelength into an electrical signal and output it. In this case, the sensor device 1 may be equipped with a bandpass filter, a spectrometer, etc. that transmits the wavelength. The photodetector 20 may detect light intensity over time and convert the light intensity over time into an electrical signal. In this case, the attenuation of the light intensity allows the attenuation of the light intensity to be measured.

[0110] In step S105, the target substance concentration calculation unit 55 calculates the concentration of the target substance based on the electrical signal output from the photodetector 20. In step S106, the target substance concentration calculated by the target substance concentration calculation unit 55 is output to the input / output unit 61 such as the display unit 11. This ends the operation flow.

[0111] Second Embodiment In one embodiment, a sensor device may have multiple sets of combination modules (hereinafter also referred to as "detection modules") of a light source, a photodetector, and a microneedle. Fig. 19A is a back view schematically showing a sensor device 100 equipped with four sets of detection modules. Fig. 19B is a cross-sectional view taken along the line B-B of the sensor device 100 in Fig. 19A.

[0112] The sensor device 100 includes, as detection modules, a detection module a including a light source 130a, a photodetector 120a, and a microneedle 140a; a detection module b including a light source 130b, a photodetector 120b, and a microneedle 140b; a detection module c including a light source 130c, a photodetector 120c, and a microneedle 140c; and a detection module d including a light source 130d, a photodetector 120d, and a microneedle 140d. The light sources 130a to 130d and the photodetectors 120a to 120d are mounted on a circuit board 150 and are arranged on the surface of the circuit board 150 facing the inner bottom surface of the housing 110.

[0113] The detection modules a to d may detect different target substances Ta to Td, respectively. In this case, the microneedle 140a includes an optical probe Pa that reacts with the target substance Ta. The microneedle 140b includes an optical probe Pb that reacts with the target substance Tb. The microneedle 140c includes an optical probe Pc that reacts with the target substance Tc. The microneedle 140d includes an optical probe Pd that reacts with the target substance Td. The light source 130a generates excitation light that excites the optical probe Pa that has reacted with the target substance Ta. The light source 130b generates excitation light that excites the optical probe Pb that has reacted with the target substance Tb. The light source 130c generates excitation light that excites the optical probe Pc that has reacted with the target substance Tc. The light source 130d generates excitation light that excites the optical probe Pd that has reacted with the target substance Td. The photodetector 120a detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe Pa that has reacted with the target substance Ta in response to excitation light. The photodetector 120b detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe Pb that has reacted with the target substance Tb in response to excitation light. The photodetector 120c detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe Pc that has reacted with the target substance Tc in response to excitation light. The photodetector 120d detects light (fluorescence, phosphorescence, Raman scattered light, etc.) generated by the optical probe Pd that has reacted with the target substance Td in response to excitation light. The light detected by the photodetectors 120a to 120d is converted into respective electrical signals and input to a target substance concentration calculation unit. The target substance concentration calculation unit calculates the concentrations of the target substances Ta to Td from the respective electrical signals. The calculated concentrations of the target substances Ta to Td are output to an output device such as a display unit 111. This allows the sensor device 100 to be used for monitoring four types of target substances Ta to Td.

[0114] The number of detection modules is not limited to 4. Examples of the number of detection modules include 2 to 20, 2 to 10, 2 to 5, 2 to 4, 2 or 3, etc.

[0115] The sensor device may be used in humans or non-human animals, including mammals such as pets (dogs, cats, rabbits, etc.) and livestock (cows, pigs, goats, sheep, etc.).

[0116] The sensor device uses a microneedle containing an optical probe to measure a target substance in a living body, allowing for easy and sensitive monitoring of the target substance. The sensor device allows the tip of the needle to reach the subcutaneous tissue by making the needle length 2 to 5 mm. This makes it easier for the tip of the needle to enter a blood vessel, allowing for accurate detection of blood components. The sensor device also allows for the measurement of high-molecular-weight target substances by providing a recess filled with a hydrogel containing an optical probe near the tip of the needle.

[0117] The present invention will be described below with reference to examples, but the present invention is not limited to the following examples.

[0118] [Fabrication of Microneedles] Microneedles were fabricated according to the method described by Kanda et al. (Y. Kanda et al., Japanese Journal of Applied Physics 58, SDDK05 (2019)) (see FIG. 20). A polydimethylsiloxane (PDMS) replica mold was fabricated using a phosphor bronze master mold (FIG. 20(a)). The master mold was fabricated by ultra-precision machining (ROBONANO α-0iB, FANUC Corp., Japan). The master mold for the microneedle had a diameter of 500 μm and a height of 2 mm, and the rod had a diameter of 300 μm and a length of 3 to 5 mm. PDMS prepolymer (BASE:CAT=10:15, Sylgard 184, Dow Corning Co., MI, USA) was poured into the master mold and maintained at 120°C for 2 hours (Figure 20(b)). The PDMS slab was then peeled off from the master mold to obtain a PDMS replica mold (Figure 20(c)). The PDMS replica mold was degassed at 10 hPa for 4 hours using a vacuum oven (THERMOVAC VT 210, Kusumoto Chemicals, Ltd., Japan). Next, poly-L-lactic acid (PLLA) pellets (Resomer L 206 s, Sigma-Aldrich Corp., USA) were placed on the PDMS replica mold (Figure 20(d)). Then, the PLLA was melted at 20 hPa and 200°C (Fig. 20e). -2 The molten PLLA was filled into the needle-shaped microstructure under a load pressure of 1000 kJ / min for 10 hours (Fig. 20(f)). After that, the PLLA in the PDMS replica mold was cooled at a rate of 200 Km / min to amorphize it. -1 Finally, the PLLA molded article was released from the PDMS replica mold to obtain a microneedle structure made of amorphous PLLA (FIG. 20(g); needle base diameter: 200-500 μm, needle length: 2-3 mm).

[0119] Example 1 (Measurement of oxygen partial pressure) Platinum-octaethyleneporphyrin (PtOEP) was used as the optical probe. PtOEP loses its phosphorescence when it reacts with oxygen. A microneedle structure was obtained in the same manner as above, except that PtOEP was mixed with PLLA.

[0120] The microneedle structure was placed in an environment with an oxygen partial pressure of 0.017 atm, 0.15 atm, or 0.21 atm. The phosphorescence generated at the needle tip was observed using an oscilloscope, and the phosphorescence lifetime was measured. The phosphorescence measurement system is shown in Figure 21.

[0121] The measurement results of the phosphorescence lifetime are shown in Figure 22. The relationship between the phosphorescence lifetime and the oxygen partial pressure is shown in Figure 23. The relationship between the phosphorescence lifetime and the oxygen partial pressure was confirmed to be linear according to the Stern-Volmer equation. These results demonstrate that in a microneedle containing an optical probe, an environmentally responsive signal can be detected by measuring the phosphorescence generated from the optical probe. Since the light irradiated onto the second surface is introduced into the needle portion via the needle substrate portion, the flatness of the region of the second surface corresponding to the region where the needle portion is formed is estimated to be 300 nm or less.

[0122] Example 2 (Blood Measurement of Fluorescently Labeled DDS Preparation) A microneedle structure was obtained using the same method as above. The fluorescently labeled DDS preparation used was the polymer micelle described in Anraku et al. (Y. Anraku, et al., Chem. Commun., 2011, 47, 6054-6056). This polymer micelle (φ=30 nm) was formed by mixing a PEG-PAsp polymer labeled with a fluorescent labeling molecule (DyLight488) and a PEG-P-(Asp-AP) polymer.

[0123] The test was performed using a microfluorescence spectroscopy system equipped with a human skin tissue model. Figure 24 shows an overview of the microfluorescence spectroscopy system. A fluorescently labeled DDS formulation was dispersed in the blood of the human skin tissue model at a concentration of 0.3 to 100 μg / mL. A microneedle was inserted into the human skin tissue model, and the fluorescently labeled DDS formulation in the blood of the human skin tissue model was measured.

[0124] The results are shown in Figure 25. A positive correlation was confirmed between the concentration of the fluorescently labeled DDS preparation dispersed in the blood (horizontal axis) and the fluorescence intensity detected from the microneedle (vertical axis) in the concentration range of 1.33 μg / mL or more. This result demonstrates that the blood concentration of the fluorescently labeled DDS preparation can be measured using a microneedle.

[0125] According to the present invention, there are provided a sensor device equipped with a microneedle that can easily measure the internal body environment, and a microneedle that can be used for the sensor device.

[0126] 1...sensor device, 10...casing, 11...display unit, 12...input unit, 20, 120a to 120d...photodetector, 30, 130a to 130d...light source, 40, 40a, 40b, 140a to 140d...microneedle, 41, 41a, 41b...needle portion, 42, 42a, 42b...recess, 43...support material, 45, 45a, 45b...needle substrate portion, 46, 46 a, 46b... alignment marks, 47, 47'... light collecting portion, 48... light reflecting layer, 50, 150... circuit board, 200, 200', 201, 202... microneedle patch, 210, 210'... fixing member, 211... base, 211'... transparent base, 212, 212'... adhesive layer, 230, 230a, 230b... protective sheet, P... optical probe, T... target substance.

Claims

1. A microneedle comprising: a needle portion having an optical waveguide; and a needle substrate portion having a first surface on which the needle portion is formed and a second surface on which the needle portion is not formed, wherein the second surface has a region having a flatness of 300 nm or less, the region including a region on the first surface corresponding to the region on which the needle portion is formed.

2. The microneedle according to claim 1, wherein the second surface has a focusing portion that focuses light incident from the second surface onto the needle portion.

3. The microneedle according to claim 1, wherein the needle substrate portion includes an alignment mark.

4. A microneedle as described in claim 1, wherein the needle portion includes an optical probe, and the optical probe includes a substance that changes the state of light generated by excitation light upon reaction with a target substance in a living body.

5. The microneedle according to claim 4, wherein the needle portion has at least one recess in a side surface, the recess being filled with a support material carrying the optical probe.

6. The microneedle according to claim 1, wherein the tip diameter of the needle portion of the microneedle is 50 to 300 μm.

7. The microneedle according to claim 1, wherein the length of the needle portion is 0.05 to 5 mm.

8. The microneedle according to claim 7, wherein the length of the needle portion is 2 to 5 mm.

9. A microneedle patch comprising: a microneedle according to any one of claims 1 to 8; and a fixing member for fixing the microneedle to the skin of a subject.

10. An internal body environment monitoring system comprising: the microneedle patch according to claim 9; and a measuring device having a light source and a photodetector.

11. A sensor device comprising: a microneedle according to any one of claims 1 to 8; a light source; and a photodetector.

Citation Information

Patent Citations

  • Micro lens array, production method and micro needle device

    JP2021129839A

  • Cutting Device For Light Guide Plate

    KR1020160078938A

  • Devices and Systems for Optically Determining a Concentration of an Analyte in a Living Subject Using Hydrogel-Based, Fluorescent Microneedles and Methods of Manufacture Thereof

    US20180177439A1

  • Needle-type biosensor

    US20220218237A1

  • Analyte detection system and method for intradermal implantation of biocompatible optode nanosensors

    US9974471B1